7qfp
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='7qfp' size='340' side='right'caption='[[7qfp]], [[Resolution|resolution]] 3.70Å' scene=''> | <StructureSection load='7qfp' size='340' side='right'caption='[[7qfp]], [[Resolution|resolution]] 3.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7QFP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7QFP FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7qfp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7qfp OCA], [https://pdbe.org/7qfp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7qfp RCSB], [https://www.ebi.ac.uk/pdbsum/7qfp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7qfp ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.7Å</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7qfp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7qfp OCA], [https://pdbe.org/7qfp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7qfp RCSB], [https://www.ebi.ac.uk/pdbsum/7qfp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7qfp ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | <div style="background-color:#fffaf0;"> | ||
| - | == Publication Abstract from PubMed == | ||
| - | Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 A for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular. | ||
| - | + | ==See Also== | |
| - | + | *[[Botulinum neurotoxin 3D structures|Botulinum neurotoxin 3D structures]] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Davies | + | [[Category: Davies JR]] |
| - | [[Category: Kosenina | + | [[Category: Kosenina S]] |
| - | [[Category: Martinez-Carranza | + | [[Category: Martinez-Carranza M]] |
| - | [[Category: Masuyer | + | [[Category: Masuyer G]] |
| - | [[Category: Stenmark | + | [[Category: Stenmark P]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Cryo-EM structure of Botulinum neurotoxin serotype E
| |||||||||||
